ATS 2020 Advance Program

investigator in basic and clinical pertinent to COPD, and sponsors of research. Objectives At the conclusion of this session, the participant will be able to: • identify challenges associated with the contemporary assessment and management of chronic obstructive pulmonary disease (COPD) based on evidence-based clinical practice guidelines recommendations; • learn new findings and gain competence in providing pharmacological and non-pharmacological management of COPD; • recognize unmet needs for future research in the field. This course will provide a state of the art update on the pathophysiology, clinical progression and course, assessment and management of COPD. It will also shed light on recent and ongoing clinical trials and outline evidence-based pharmacological and non-pharmacological management strategies. In addition, interventions to prevent of COPD exacerbation will be discussed. Attendees will be updated on the evolving knowledge on COPD phenotypes, endotypes and biomarkers as well as recent advances in understanding the genetic aspect of this disease. Finally, the course will also outline unmet and future research needs. Chairing: N.A. Hanania, MD, MS, ATSF, Houston, TX J.M. Bon, MD, MS, ATSF, Pittsburgh, PA M.T. Dransfield, MD, Birmingham, AL R. Kalhan, MD, MS, Chicago, IL 8:00 Introduction N.A. Hanania, MD, MS, ATSF, Houston, TX 8:05 Disease Progression of COPD: What Have We Learned from Clinical and Cohort Studies? R. Kalhan, MD, MS, Chicago, IL 8:25 Novel Insights on the Immunopathology of COPD P.J. Barnes, MD, DSc, ATSF, London, United Kingdom 8:45 Insights from COPD Genetics C.P. Hersh, MD, MPH, ATSF, Boston, MA 9:05 The Role of Microbiome in COPD: Evolving Knowledge Y.J. Huang, MD, Ann Arbor, MI 9:25 New Concepts in the Diagnosis and Management of Chronic Bronchitis V. Kim, MD, ATSF, Philadelphia, PA 9:45 Questions and Answers 9:55 Break 10:10 Biomarkers for COPD: Are We There Yet? D. Singh, MD, NP, Manchester, United Kingdom 10:30 Role of Radiologic Imaging in COPD G.R. Washko, MD, Boston, MA 10:50 Prevention of COPD Exacerbations J.A. Wedzicha, MD, PhD, ATSF, London, United Kingdom 11:10 GOLD 2020: An Update G.J. Criner, MD, ATSF, Philadelphia, PA 11:30 Questions and Answers 11:50 LUNCH 12:50 Bronchoscopic Interventions in COPD F.C. Sciurba, MD, Pittsburgh, PA 1:10 Non-Invasive Ventilation in COPD N. Hart, MD, London, United Kingdom 1:30 Pulmonary Rehabilitation at Home: Can It Be Done? A.E. Holland, PhD, Melbourne, Australia 1:50 Assessment and Management of Comorbidities in COPD J.M. Bon, MD, MS, ATSF, Pittsburgh, PA 2:10 Promoting Self-Management in COPD R. Benzo, MD, MSc, Rochester, MN 2:30 Questions and Answers 2:40 Break 2:45 Bronchodilators in COPD: An Update N.A. Hanania, MD, MS, ATSF, Houston, TX 3:05 Inhaled Steroids in COPD: Friend or Foe? M.T. Dransfield, MD, Birmingham, AL ATS 2020 • Philadelphia, PA FRIDAY • MAY 15 7